Immunizations in adolescents-an update

Adolescent Medicine: State of the Art Reviews

Volumn 21, Issue 2, 2010, Pages 173-186

  Edwards, Sharon M ^a   Rousseau Pierre, Thaina ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ELMHURST HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; FEMALE; HUMAN; IMMUNIZATION; INFECTION CONTROL; MALE; MEDICINE; METHODOLOGY; REVIEW; UNITED STATES;

ADOLESCENT; ADOLESCENT MEDICINE; COMMUNICABLE DISEASE CONTROL; FEMALE; HUMANS; IMMUNIZATION; IMMUNIZATION SCHEDULE; MALE; UNITED STATES;

EID: 79952112540     PISSN: 19344287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. American Academy of Pediatrics. Recommended childhood and adolescent immunization schedules United States, 2010. Pediatrics. 2010: 125(1): 195-196
2. Centers for Disease Control and Prevention. National, state and local area vaccination coverage among adolescents aged 13-17 years-United States, 2008. MMWR. 2009;58(36):997-1001
3. Brown DR, Schroeder JM, Bryan JY, et al. Detection of multiple human papilloma virus types in condyloma acuminate lesions from otherwise healthy and immunosuppressed patients. J Clinical Microbiology. 1999;37:3316-3322 (Pubitemid 29455226)
4. Garcia F, Saslow D. Prophylactic human papillomavirus vaccination: a breakthrough in primary cervical cancer prevention. Obstet Gynecol Clin. 2007;34
5. Moscicki A. HPV vaccines: today and in the future. J Adolescent Health. 2008;43:S26-S40
6. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiology. 2000;151(12):1158-1171 (Pubitemid 30451948)
7. FDA approves new vaccine for the prevention of cervical cancer. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm 187048.htm. Accessed January 15, 2010
8. FDA approval letter to expand Gardisil to males. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186991. htm. Accessed January 12, 2010
9. Diaz M. Human papilloma virus-prevention and treatment. Obstet Gynecol Clin North Am. 2008;35:199-217
10. Ackerman L. Update on immunizations in children and adolescents. Am Family Physician. 2008;77:1561-1568
11. Rodewald L, Orenstein W. Vaccinating adolescents-new evidence of challenges and opportunities. J Adolescent Health. 2009;45:427-429
12. Bernat D, Harpin S, Eisenberg M, Bearinger L, Resnick M. Parental support for the human papillomavirus vaccine. 2009;45:525-527
13. Wright S, Edwards K, Decker M, Zeldin M. Pertussis infection in adults with persistent cough. JAMA. 1995;273:1044-1046
14. Pichiero M, Blatter M, Kennedy W, Hedrick J, Descamps D, Friedland L. Acellular pertussis vaccine booster combined with diptheria and tetanus toxoids for adolescents. Pediatrics. 2006; 117:1084-1093 (Pubitemid 46071499)
15. Craig A, Wright S, Edwards K, Greene J, et al. Outbreak of pertussis on a college campus. Am J Med. 2007;120:364-368 (Pubitemid 46483311)
16. Nennig M, Shinefield H, Edwards K, et al. Prevalence and incidence of adult pertussis in an urban population. JAMA. 1996;275:1672-1674 (Pubitemid 26175816)
17. Middleman A, Rosenthal S, Rickert V, Neinstein L, Fishbein D, D'Angelo L. Adolescent immunizations: A position paper of the Society for Adolescent Medicine. J Adolescent Health. 2006;38:321-327 (Pubitemid 43247530)
18. Centers for Disease Control and Prevention. Prevention and control of meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices. MMWR. 2005;54(RR-07): 1-21
19. Harrison L, Pass M, Mendelsohn A, et al. Invasive meningococcal disease in adolescents and young adults. JAMA. 2001;286:694
20. Beernink P, Welsch J, Harrison L, et al. Prevalence of factor H- binding protein variants and NadA among meningococcal group B isolates from the United States: Implications for the development of a multicomponent group B vaccine. J Infectious Dis. 2007;195:1472
21. Keyserling H, Papa T, Koranhyi K, et al. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A,C,Y and W-135) polysaccharide diptheroid toxoid conjugate vaccine (MCV-4) in healthy adolescents. Arch Pediatr Adolesc Med. 2005;159:907
22. Centers for Disease Control and Prevention. Revised recommendations of the advisory board on immunization practices to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine. MMWR. 2007;56(31):794-795
23. Centers for Disease Control and Prevention. Updated recommendation from the Advisory Committee on Immunization Practices for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR. 2009;58(37): 1042-1043
24. Centers for Disease Control and Prevention. Update: Guillain-Barre' syndrome among recipients of menactra meningococcal conjugate vaccine-United States, June 2005-September 2006. MMWR. 2006;55(41):1120-1124
25. Thompson W, Shay D, Weintraub, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-186 (Pubitemid 36068705)
26. Hannoun C. Immunogenicity and protective efficacy of influenza vaccination. Virus Res. 2004; 103:133-138 (Pubitemid 38649072)
27. Fiore A, Shay D, Broder K, et al. Prevention and control of seasonal influenza with vaccines. MMWR. 2009;58:1-52
28. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009: Use of the influenza A (H1N1) 2009 monovalent vaccine. MMWR. 2009;58:1-8
29. Singleton J, Santibanez T, Lu P, et al. Interim results: Influenza A (H1N1) 2009 monovalent vaccination coverage-United States. MMWR. 2009;59:44-48
30. Center for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. 11th edition. Washington, DC: Public Health Foundation, 2009
31. Centers for Disease Control. Notice to readers update: recommendations to prevent hepatitis B virus transmission-United States. MMWR. 1995;44:574-575
32. Mast E, Margolis H, Fiore A, et al. A comprehensive strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the ACIP. MMWR. 2005; 54(RR-16):1-33
33. Centers for Disease Control and Prevention. Surveillance for acute viral hepatitis-United States, 2006. MMWR. 2008;198:299-304
34. Centers for Disease Control and Prevention. Prevention of hepatitis a through active or passive immunization: recommendations of the ACIP. MMWR. 2006;55(RR07): 1-23
35. Jain N, Hennessey K. Hepatitis B vaccination coverage among US adolescents, National Immunization Survey-Teen, 2006. J Adolescent Health. 2009;44:561-567
36. Committee on Infectious Diseases. Hepatitis A Recommendations. Pediatrics. 2007; 120:189-199
37. National Immunization Program, Centers for Disease Control and Prevention. Needle Tips and the Hepatitis B Coalition News. 1999;9:13-15
38. Weisberg S. Mumps. MMWR. 2007;53:484-487 (Pubitemid 350086585)
39. Centers for Disease Control and Prevention. Mumps Outbreak-New York, New Jersey, Quebec, 2009. MMWR. 2009;58:1270-1274
40. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. 11th ed. Washington, DC: Public Health Foundation, 2009
41. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: updated recommendations of the Advisory Committee on Immunization Practices. MMWR. 2000;49:RR-05
42. Centers for Disease Control and Prevention. Prevention of pneumococcal disease recommendations of the Advisory Committee on Immunization Practices (ACIP). MMRW. 1997;46:RR-8
43. Centers for Disease Control and Prevention. Bacterial Co-infections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May-August 2009. MMRW. 2009;58:1-4
44. Centers for Disease Control and Prevention. ACIP Provisional Recommendations for Use of Pneumococcal Vaccines. Available at: http://www.cdc.gov/vaccines/recs/provisional/downloads/pneumo-oct-2008-508.pdf. Accessed January 14, 2010
45. Centers for Disease Control and Prevention. Syncope after vaccination-United States, January 2005-July 2007. MMWR. 2008;57:457-460
46. Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the ACIP. MMWR. 2006;55:RR-15
47. McCormick M, Bayer R, Berg A, et al. Report of the Institute of Medicine. Immunization safety review: vaccine and autism. Washington, DC: Institute of Medicine; 2004
48. Gardasil pricing information. Available at: www.cdc.gov/std/hpv/STDFact- HPV-vaccine-young-women.htm#hpv. Accessed January 18, 2010
49. Central for Disease Control and Prevention. Health United States 2005. Available at: http://www.cdc.gov/nchs/data/hus/hus0.5.pdf. Accessed July 1, 2009
50. Lindley M, Boyer-Chu L, Fishbein D, Kolasa M, et al. The role schools in strengthening delivery of new adolescent vaccinations. Pediatrics. 2008;121:S46-S54
51. Schaffer S, Fontanesi J, Rickert D, et al. How effectively can health care settings beyond the traditional medical home provide vaccines to adolescents? Pediatrics. 2008;121:S35-S45
52. Middleman A. Adolescent immunizations: policies to provide a shot in the arm for adolescents. J Adolescent Health. 2007;41:109-118 (Pubitemid 47058982)